Search

Displaying results 521 - 530 of 8970 in total
  1. Indication

    Mild to Moderate Ulcerative Colitis

    go.drugbank.com/conditions/DBCOND0045616
    Drugs: Mesalazine · Sulfasalazine
    Synonyms: Mild-to-moderate Ulcerative Colitis, Mild to Moderate Ulcerative Colitis
  2. Indication

    Moderate to Severe Atopic Dermatitis

    go.drugbank.com/conditions/DBCOND0031699
    Drugs: Dupilumab · Tralokinumab
    Synonyms: Moderate-to-Severe Atopic Dermatiti, Moderate-to-severe Atopic Dermatitis
  3. Indication

    Moderate to Severe Plaque Psoriasis

    go.drugbank.com/conditions/DBCOND0040433
    Drugs: Certolizumab pegol · Ixekizumab · Methotrexate · Mometasone furoate · Tildrakizumab
    Synonyms: Moderate-to-severe Plaque Psoriasis, Moderate to Severe Plaque Psoriasis
  4. Indication

    Moderate to Severe Rheumatoid Arthritis

    go.drugbank.com/conditions/DBCOND0065339
    Drugs: Abatacept · Adalimumab · Indomethacin · Tocilizumab
    Synonyms: Moderate to Severe Rheumatoid Arthritis, Moderate-to-severe Rheumatoid Arthritis
  5. Indication

    Moderate to Severe Ulcerative Colitis

    go.drugbank.com/conditions/DBCOND0069179
    Drugs: Tofacitinib
    Synonyms: Moderate to Severe Ulcerative Colitis
  6. Indication

    Necatoriasis due to necator americanus

    go.drugbank.com/conditions/DBCOND0022061
    Drugs: Levamisole · Mebendazole
    Synonyms: Necatoriasis due to necator americanus, Necatoriasis due to Necator americanus (disorder)
  7. Drug

    Ibuprofen

    go.drugbank.com/drugs/DB01050
    ApprovedInvestigational

    Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer _in vivo_ by the activity of the alpha-methylacyl-CoA racemase. … [A39074] The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin.

    Mixtures: FORT-GRIP, Period Pills by BiikayCategories: Topical Products for Joint and Muscular Pain, Experimental Unapproved Treatments for COVID-19
  8. Drug

    Corifollitropin alfa

    go.drugbank.com/drugs/DB09066
    ApprovedInvestigational

    Elonva is available only by prescription [L2270]. In July 2014, Merck announced the receipt of a Complete Response Letter (CRL) from the U.S. FDA for its New Drug Application for this drug. … This means that it is made by cells into which a DNA has been introduced that makes them able to produce corifollitropin alfa [L2270].

    Products: Elonva Solution for Injection 150mcg/0.5ml, Elonva Solution for Injection 100mcg/0.5ml
  9. Drug

    Eculizumab

    go.drugbank.com/drugs/DB01257
    ApprovedInvestigational

    [L6919] In Q1 2023, the EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion of two formulations of eculizumab indicated for the treatment of paroxysmal nocturnal hemoglobinuria … [L6919,A2245] Binding to this protein prevents the activation of a complement terminal complex, which is used to treat a number of autoimmune conditions.

    Products: Soliris Concentrate for Solution for Infusion 300mg/vial, Soliris 10mg/ml Concentrate for Solution for Infusion
  10. Drug

    Satralizumab

    go.drugbank.com/drugs/DB15762
    ApprovedInvestigational

    [A218551] It received subsequent approvals in Switzerland and Japan,[A218551] and was approved for use by the FDA in August 2020,[L15566] becoming the 3rd treatment to receive FDA approval for NMOSD (after … This novel mechanism effectively increases the duration of action of satralizumab, as it allows for single drug molecules to interact with multiple endogenous IL-6 receptors prior to elimination.

    Products: ENSPRYNG SOLUTION FOR INJECTION IN PREFILLED SYRINGE 120MG/1ML, ENSPRYNG 120 mg/1ml solution for injection in pre-filled syringe